Abnormal WNT/β-catenin pathway can be observed in a variety of cancers like breast cancer, colorectal cancer, and hepatocellular carcinoma [19–21], which often acts as the upstream carcinogenic signal of MYC and participates in the process of proliferation, apoptosis, and angiogenesis [22]. This evidence concerns the gene MYC and cancer.